Wall Street is positive on Companhia Brasileira de Distribuicao (CBD). On average, analysts give CBD a Strong Buy rating. The average price target is $21.25, which means analysts expect the stock to rise by 47.47% over the next twelve months.
That average ranking earns CBD an Analyst Rating of 80, which is better than 80% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
Investors Observer averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What's Happening With Companhia Brasileira de Distribuicao Stock Today?
Companhia Brasileira de Distribuicao (CBD) stock is trading at $14.41 as of 11:56 AM on Thursday, Jul 30, a drop of -$0.65, or -4.32% from the previous closing price of $15.06. The stock has traded between $14.40 and $15.05 so far today. Volume today is below average. So far 122,972 shares have traded compared to average volume of 369,009 shares.